Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, December 15, 2011

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

Pictured: Structural formula of IBNtxA
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 13, 2011

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 12, 2011

A Memorial Sloan Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Pictured: David Solit
In the Lab
By Media Staff  |  Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Center News

Stay Informed

Get the latest information about cancer care and research every month.